Back to search

Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease

Data up to Jan 2025

Published1997
Citations83
References33

Total Citations Per Year

Abstract

References (33)

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1981 • 3,549 citations

Classification of chronic hepatitis: Diagnosis, grading and staging

1994 • 2,506 citations

A CLASSIFICATION OF CHRONIC HEPATITIS

1968 • 856 citations

Transforming Growth Factors β1 and α in Chronic Liver Disease

1991 • 655 citations

The Matrix Metalloproteinases and Their Inhibitors

1992 • 604 citations

Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.

1989 • 604 citations

Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression

1991 • 461 citations

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver

1996 • 349 citations

Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA)

1991 • 278 citations

[30] Tissue inhibitors of matrix metalloendopeptidases

1995 • 263 citations

Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase.

1985 • 220 citations

Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.

1992 • 207 citations

Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases An application for rheumatoid arthritis serum and plasma

1990 • 176 citations

Increased transforming growth factor-β1 gene expression in human liver disease

1992 • 132 citations

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology

1994 • 128 citations

Levels of circulating collagenase, stromelysin‐1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis: relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation

1995 • 123 citations

Tissue Inhibitor of Metalloproteinase-1 and Interstitial Collagenase Expression in Autoimmune Chronic Active Hepatitis and Activated Human Hepatic Lipocytes

1995 • 112 citations

Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis

1982 • 111 citations

Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis

1994 • 94 citations

Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures

1993 • 85 citations

Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts

1991 • 84 citations

Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis

1994 • 65 citations

Quantitative analysis of transforming growth factor β1 messenger RNA in the liver of patients with chronic hepatitis C: Absence of correlation between high levels and severity of disease

1995 • 57 citations

Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma

1993 • 56 citations

Synthesis of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in human hepatoma cells (HepG2) Up‐regulation by interleukin‐6 and transforming growth factor β1

1992 • 56 citations

Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseases

1993 • 48 citations

Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas

1996 • 47 citations

Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas

1996 • 45 citations

Plasma transforming growth factor‐β1 concentrations in patients with chronic viral hepatitis

1998 • 43 citations

Tumor Necrosis Factor-α Induces mRNA for Collagenase and Timp in Human Skin Fibroblasts

1990 • 35 citations

High Metalloproteinase Inhibitor Content of Human Cirrhosis and Its Possible Conference of Metastasis Resistance2

1988 • 29 citations

Serum collagenase activity in patients with chronic liver disease

1993 • 25 citations

Serum markers for fibrosis and plasma transforming growth factor‐β1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis

1996 • 17 citations

Cited By (0)

Loading...